21 – 30 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
(
- Contribution to journal › Scientific review
-
Mark
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)
(
- Contribution to journal › Article
- 2003
-
Mark
Adapting the rheumatoid arthritis quality of life instrument (RAQoL) for use in Sweden - a comment
(
- Contribution to journal › Letter
-
Mark
The cost-effectiveness of infliximab (Remicade((R))) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.
(
- Contribution to journal › Article
-
Mark
Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis.
(
- Contribution to journal › Article
- 2002
-
Mark
Modeling the progression of rheumatoid arthritis - A two-country model to estimate costs and consequences of rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Measuring health related quality of life in patients with rheumatoid arthritis--reliability, validity, and responsiveness of a Swedish version of RAQoL.
(
- Contribution to journal › Article
-
Mark
Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
- 2001
-
Mark
Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis
(
- Contribution to journal › Article